Peter G. Smith

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Teresa A. Soucy, Peter G. Smith, Michael A. Milhollen et al. · Nature · 2009 · 2K citations

Novel Therapy, Medicine, New Approach +9

Development of a syngeneic mouse model for events related to ovarian cancer

Katherine F. Roby, Christopher Taylor, J. P. Sweetwood et al. · Carcinogenesis · 2000 · 588 citations · Full text

SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Eun Hee Kim, Janine O. Ilagan, Yang Liang et al. · Cancer Cell · 2015 · 558 citations · Full text

Genome Instability, Somatic Variant, Genetics +8

Subtype and pathway specific responses to anticancer compounds in breast cancer

Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo et al. · Proceedings of the National Academy of Sciences · 2011 · 501 citations

Drug Target, Breast Oncology, Chemoprevention Strategy +17

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

Michael Seiler, Akihide Yoshimi, Rachel Darman et al. · Nature Medicine · 2018 · 491 citations · Full text

Tumor Biology, Medicine, Rna Splicing +9